Reduction of ethanol-induced ocular abnormalities in mice through dietary administration of N-acetylcysteine

Alcohol

Volumn 44, Issue 7-8, 2010, Pages 699-705

  Parnell, Scott E ^a   Sulik, Kathleen K ^a   Dehart, Deborah B ^a   Chen, Shao yu ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Fetal alcohol spectrum disorders; N Acetylcysteine; Ocular abnormalities

Indexed keywords

ACETYLCYSTEINE; ALCOHOL;

ALCOHOL BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; DIET; DISEASE SEVERITY; DRUG EFFICACY; EYE DISEASE; FEMALE; FETAL ALCOHOL SYNDROME; FETUS WEIGHT; GESTATIONAL AGE; INCIDENCE; LIQUID; LOW DRUG DOSE; MOUSE; NONHUMAN; PREGNANCY; TERATOGENICITY;

ACETYLCYSTEINE; ANIMALS; DIET; DISEASE MODELS, ANIMAL; ETHANOL; EYE ABNORMALITIES; FEMALE; FETAL ALCOHOL SYNDROME; GESTATIONAL AGE; MALE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C57BL; PREGNANCY;

MUS;

EID: 78649636578     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2010.05.006     Document Type: Article

References (48)

1. Aoto K., Shikata Y., Higashiyama D., Shiota K., Motoyama J. Fetal ethanol exposure activates protein kinase A and impairs Shh expression in prechordal mesendoderm cells in the pathogenesis of holoprosencephaly. Birth Defects Res. A Clin Mol. Teratol. 2008, 82:224-231.
2. Atkuri K.R., Mantovani J.J., Herzenberg L.A. N-Acetylcysteine-a safe antidote for cysteine/glutathione deficiency. Curr. Opin. Pharmacol 2007, 7:355-359.
3. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 1997, 25:335-358.
4. Chen S.Y., Sulik K.K. Free radicals and ethanol-induced cytotoxicity in neural crest cells. Alcohol. Clin. Exp. Res. 1996, 20:1071-1076.
5. Chen S.Y., Sulik K.K. Iron-mediated free radical injury in ethanol-exposed mouse neural crest cells. J. Pharmacol. Exp. Ther. 2000, 294:134-140.
6. Chen S.Y., Dehart D.B., Sulik K.K. Protection from ethanol-induced limb malformations by the superoxide dismutase/catalase mimetic, EUK-134. FASEB J. 2004, 18:1234-1236.
7. Clancy R.M., Levartovsky D., Leszczynska-Piziak J., Yegudin J., Abramson S.B. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3680-3684.
8. Cohen-Kerem R., Koren G. Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. Neurotoxicol. Teratol. 2003, 25:1-9.
9. Cook C.S., Nowotny A.Z., Sulik K.K. Fetal alcohol syndrome. Eye malformations in a mouse model. Arch. Ophthalmol. 1987, 105:1576-1581.
10. Cotgreave I.A. N-Acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv. Pharmacol. 1997, 38:205-227.
11. Davis W.L., Crawford L.A., Cooper O.J., Farmer G.R., Thomas D.L., Freeman B.L. Ethanol induces the generation of reactive free radicals by neural crest cells in vitro. J. Craniofac. Genet. Dev. Biol. 1990, 10:277-293.
12. Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 2005, 365:1552-1560.
13. Dekhuijzen P.N. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur. Respir. J. 2004, 23:629-636.
14. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005, 353:2229-2242.
15. Dong J., Sulik K.K., Chen S.Y. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid. Redox. Signal 2008, 10:2023-2033.
16. Glazner G.W., Boland A., Dresse A.E., Brenneman D.E., Gozes I., Mattson M.P. Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death. J. Neurochem. 1999, 73:2341-2347.
17. Green C.R., Watts L.T., Kobus S.M., Henderson G.I., Reynolds J.N., Brien J.F. Effects of chronic prenatal ethanol exposure on mitochondrial glutathione and 8-iso-prostaglandin F2alpha concentrations in the hippocampus of the perinatal guinea pig. Reprod. Fertil. Dev. 2006, 18:517-524.
18. Heaton M.B., Mitchell J.J., Paiva M. Amelioration of ethanol-induced neurotoxicity in the neonatal rat central nervous system by antioxidant therapy. Alcohol. Clin. Exp. Res. 2000, 24:512-518.
19. Henderson G.I., Chen J.J., Schenker S. Ethanol, oxidative stress, reactive aldehydes, and the fetus. Front. Biosci. 1999, 4:D541-550.
20. Kanter M.Z. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am. J. Health Syst. Pharm. 2006, 63:1821-1827.
21. Koppal T., Drake J., Yatin S., Jordan B., Varadarajan S., Bettenhausen L., et al. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 1999, 72:310-317.
22. Kotch L.E., Chen S.Y., Sulik K.K. Ethanol-induced teratogenesis: free radical damage as a possible mechanism. Teratology 1995, 52:128-136.
23. Kotch L.E., Dehart D.B., Alles A.J., Chernoff N., Sulik K.K. Pathogenesis of ethanol-induced limb reduction defects in mice. Teratology 1992, 46:323-332.
24. Lacy C.F. Lexi-Comp's Drug Information Handbook 2009-2010 2009, Lexi-Comp, Hudson, Ohio. 18 ed.
25. Lieber C.S., DeCarli L.M. Alcoholic liver injury: experimental models in rats and baboons. Adv. Exp. Med. Biol. 1975, 59:379-393.
26. Lieber C.S., DeCarli L.M. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol. Clin. Exp. Res. 1982, 6:523-531.
27. Marenzi G., Assanelli E., Marana I., Lauri G., Campodonico J., Grazi M., et al. N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty. N. Engl. J. Med. 2006, 354:2773-2782.
28. Martinez S.E., Egea G. Novel molecular targets for the prevention of fetal alcohol syndrome. Recent Patents CNS Drug. Discov. 2007, 2:23-35.
29. Parnell S.E., Dehart D.B., Wills T.A., Chen S.Y., Hodge C.W., Besheer J., et al. Maternal oral intake mouse model for fetal alcohol spectrum disorders: ocular defects as a measure of effect. Alcohol. Clin. Exp. Res. 2006, 30:1791-1798.
30. Parnell S.E., Chen S.Y., Charness M.E., Hodge C.W., Dehart D.B., Sulik K.K. Concurrent dietary administration of D-SAL and ethanol diminishes ethanol's teratogenesis. Alcohol. Clin. Exp. Res. 2007, 31:2059-2064.
31. Peng Y., Kwok K.H., Yang P.H., Ng S.S., Liu J., Wong O.G., et al. Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents ethanol-induced growth retardation and microencephaly. Neuropharmacology 2005, 48:426-434.
32. Pierce D.R., Cook C.C., Hinson J.A., Light K.E. Are oxidative mechanisms primary in ethanol induced Purkinje neuron death of the neonatal rat?. Neurosci. Lett. 2006, 400:130-134.
33. Piperno E., Berssenbruegge D.A. Reversal of experimental paracetamol toxicosis with N-acetylcysteine. Lancet 1976, 2:738-739.
34. Ramachandran V., Watts L.T., Maffi S.K., Chen J., Schenker S., Henderson G. Ethanol-induced oxidative stress precedes mitochondrially mediated apoptotic death of cultured fetal cortical neurons. J. Neurosci. Res. 2003, 74:577-588.
35. Reimers M.J., La Du J.K., Periera C.B., Giovanini J., Tanguay R.L. Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol. Teratol 2006, 28:497-508.
36. Satiroglu-Tufan N.L., Tufan A.C. Amelioration of ethanol-induced growth retardation by all-trans-retinoic acid and alpha-tocopherol in shell-less culture of the chick embryo. Reprod. Toxicol. 2004, 18:407-412.
37. Sheth D.S., Tajuddin N.F., Druse M.J. Antioxidant neuroprotection against ethanol-induced apoptosis in HN2-5 cells. Brain Res. 2009, 1285:14-21.
38. Spong C.Y., Abebe D.T., Gozes I., Brenneman D.E., Hill J.M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 2001, 297:774-779.
39. Steingart R.A., Solomon B., Brenneman D.E., Fridkin M., Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J. Mol. Neurosci. 2000, 15:137-145.
40. Sulik K.K. Critical periods for alcohol teratogenesis in mice, with special reference to the gastrulation stage of embryogenesis. Ciba Found. Symp. 1984, 105:124-141.
41. Sulik K.K., Johnston M.C. Sequence of developmental alterations following acute ethanol exposure in mice: craniofacial features of the fetal alcohol syndrome. Am. J. Anat. 1983, 166:257-269.
42. Sulik K.K., Johnston M.C., Webb M.A. Fetal alcohol syndrome: embryogenesis in a mouse model. Science 1981, 214:936-938.
43. Watts L.T., Rathinam M.L., Schenker S., Henderson G.I. Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death. J. Neurosci. Res. 2005, 80:655-666.
44. Webster W.S., Walsh D.A., Lipson A.H., McEwen S.E. Teratogenesis after acute alcohol exposure in inbred and outbred mice. Neurobehav. Teratol. 1980, 2:227-234.
45. Wentzel P., Eriksson U.J. Genetic influence on dysmorphogenesis in embryos from different rat strains exposed to ethanol in vivo and in vitro. Alcohol. Clin. Exp. Res. 2008, 32:874-887.
46. Wilkes J.M., Clark L.E., Herrera J.L. Acetaminophen overdose in pregnancy. South. Med. J. 2005, 98:1118-1122.
47. Winterbourn C.C., Metodiewa D. The reaction of superoxide with reduced glutathione. Arch. Biochem. Biophys. 1994, 314:284-290.
48. Zafarullah M., Li W.Q., Sylvester J., Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol. Life Sci. 2003, 60:6-20.